SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.880
+0.620 (19.02%)
At close: Nov 1, 2024, 4:00 PM
3.620
-0.260 (-6.70%)
After-hours: Nov 1, 2024, 5:27 PM EDT

SAB Biotherapeutics Statistics

Total Valuation

SABS has a market cap or net worth of $35.81 million. The enterprise value is -$1.90 million.

Market Cap 35.81M
Enterprise Value -1.90M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, after market close.

Earnings Date Nov 11, 2024
Ex-Dividend Date n/a

Share Statistics

SABS has 9.23 million shares outstanding. The number of shares has increased by 61.54% in one year.

Shares Outstanding 9.23M
Shares Change (YoY) +61.54%
Shares Change (QoQ) +0.14%
Owned by Insiders (%) 16.26%
Owned by Institutions (%) 19.92%
Float 5.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.94
Forward PS n/a
PB Ratio 0.65
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.24, with a Debt / Equity ratio of 0.12.

Current Ratio 5.24
Quick Ratio 4.97
Debt / Equity 0.12
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -144.41

Financial Efficiency

Return on equity (ROE) is -122.49% and return on invested capital (ROIC) is -75.23%.

Return on Equity (ROE) -122.49%
Return on Assets (ROA) -58.80%
Return on Capital (ROIC) -75.23%
Revenue Per Employee $48,773
Profits Per Employee -$707,373
Employee Count 57
Asset Turnover 0.06
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.20% in the last 52 weeks. The beta is 0.70, so SABS's price volatility has been lower than the market average.

Beta (5Y) 0.70
52-Week Price Change -61.20%
50-Day Moving Average 2.80
200-Day Moving Average 3.68
Relative Strength Index (RSI) 70.74
Average Volume (20 Days) 135,384

Short Selling Information

The latest short interest is 79,819, so 0.86% of the outstanding shares have been sold short.

Short Interest 79,819
Short Previous Month 41,472
Short % of Shares Out 0.86%
Short % of Float 1.33%
Short Ratio (days to cover) 1.53

Income Statement

In the last 12 months, SABS had revenue of $2.78 million and -$40.32 million in losses. Loss per share was -$5.29.

Revenue 2.78M
Gross Profit -20.31M
Operating Income -45.79M
Pretax Income -40.32M
Net Income -40.32M
EBITDA -40.91M
EBIT -45.79M
Loss Per Share -$5.29
Full Income Statement

Balance Sheet

The company has $37.33 million in cash and $5.34 million in debt, giving a net cash position of $31.98 million or $3.47 per share.

Cash & Cash Equivalents 37.33M
Total Debt 5.34M
Net Cash 31.98M
Net Cash Per Share $3.47
Equity (Book Value) 46.12M
Book Value Per Share 5.00
Working Capital 32.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$37.08 million and capital expenditures -$334,755, giving a free cash flow of -$37.42 million.

Operating Cash Flow -37.08M
Capital Expenditures -334,755
Free Cash Flow -37.42M
FCF Per Share -$4.05
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,647.04%
Pretax Margin -1,450.33%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -1,344.30%

Dividends & Yields

SABS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -61.54%
Shareholder Yield -61.54%
Earnings Yield -134.01%
FCF Yield -124.36%

Analyst Forecast

The average price target for SABS is $12.40, which is 219.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.40
Price Target Difference 219.59%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 5, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Jan 5, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

SABS has an Altman Z-Score of -2.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.47
Piotroski F-Score 2